Biogen MA Inc. v. EMD Serono, Inc.

Where the novelty of a method of administration rests wholly on the novelty of the composition administered, which in turn rests on a source limitation, the anticipation analysis for the method claim necessarily reaches the same conclusion as for the composition.

Generated summary for orientation only — not legal advice. Verify against the opinion.